P. Ind (East Acton, United Kingdom), J. O. Lotvall (Gothenburg, Sweden)
Induced sputum: standardisation of methods and cell counts in a multi-centre trial
A. Efthimiadis, S. Chaibolliez, J. Milot, S. Ferreira, S. West, M. M. M. Pizzichini, E. Pizzichini, F. E. Hargreave (Hamilton, Canada)
|  |
Expression of the glucocorticoid β receptor in the sputum of moderate and severe asthmatics
J. Y. Shannon, M. Fukakusa, D. Y. M. Leung, R. Olivenstein, C. Lemiere, J. G. Martin, Q. Hamid (Montreal, Canada; Denver)
| |
Salbutamol but not ipratropium fully abolish leukotriene D4-induced gas exchange abnormalities and induced sputum eosinophilia in asthma
F. P. Gómez, A. Casas, B. Dahlen, S. E. Dahlen, J. A. Barberà, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain; Stockholm, Sweden)
| |
ICAM 1 is upregulated in exhaled air but not in induced sputum of asthmatic patients after antigenic bronchoprovocation
R. H. Zwick, K. Patocka, M. Greger, O. Pachinger, H. Zwick (Innsbruck, Vienna, Austria)
| |
Changes in sputum concentrations of leukotrienes and thromboxane after dry air hyperventilation in asthmatic patients
P. Arvidsson, M. Sjöstrand, M. Palmqvist, J. Lötvall (Gothenburg, Sweden)
| |
CD31 (PECAM-1), a specific marker of angiogenesis shows increased expression in mild asthmatic tissue
G. W. Clarke, A. M. Gonzalez, S. D. Greenaway, A. Greenough, B. J. O'Connor (London, United Kingdom)
| |
Bronchial biopsy can not be recommended to discriminate asthma and COPD in routine practice
A. Bourdin, I. Serre, D. Neveu, P. Aubas, P. Godard, P. Chanez (Montpellier, France)
| |
Plasma levels of sP- and sL-selectin in early and late asthmatic responders after allergen challenge
J. Beier, S. Korn, D. Semmler, K. M. Beeh, O. Kornmann, R. Buhl (Mainz, Germany)
| |
Carbon monoxide levels in exhaled air do not correlate with airway responsiveness after antigenic bronchoprovocation of asthmatics
R. H. Zwick, K. Patocka, M. Greger, O. Pachinger, H. Zwick (Innsbruck, Vienna, Austria)
| |
Exhaled carbon monoxide in asthma: a prospective study
P. Pearson, A. Fogarty, S. Lewis, J. Britton (United Kingdom)
| |
Levels of exhaled nitric oxide (e-NO) are related to acid-induced hyper-responsiveness to MCh in non-atopic patients with gastro-esophageal reflux (GER) and persistent cough
C. Pomari, C. Micheletto, S. Tognella, R. W. Dal Negro (Bussolengo, Italy)
| |
Warm air inhalation increases exhaled nitric oxide and carbon monixide levels in normal subjects
P. Paredi, S. A. Kharitonov, P. J. Barnes (London, United Kingdom)
| |
The effect of a leukotriene antagonist, pranlukast, on allergen-induced airway responses and circulating dendritic cells in subjects with atopic asthma
K. Parameswaran, L. Hong, A. Fanat, R. Watson, G. Obminski, D. P. Snider, P. M. O'Byrne (Hamilton, Canada)
| |
Adenosine 5’ – triphosphate (ATP) and adenosine 5' – monophosphate (AMP) challenge testing in current smokers and patients with chronic obstructive pulmonary disease (COPD)
O. Kacmaz Basoglu, C. Brindicci, S. Essilfie-Quaye, P. J. Barnes, S. A. Kharitonov (Izmir, Turkey; London, United Kingdom)
| |
An indirect bronchoprovocation challenge test using the dry powder 'Mannitol' in mild COPD-patients
J. D. Leuppi, R. Tandjung, S. D. Anderson, M. H. Brutsche, C. Surber, R. Bingisser, A. P. Perruchoud, M. Tamm (Basel, Switzerland; Sydney, Australia)
| |
Distinct clinical and biochemical responses to aspirin provocation challenge
M. Swierczynska, E. Nizankowska, J. Radwan, A. Cmiel, A. Szczeklik (Cracow, Poland)
| |
Different alcohols activate airway sensory nerves by a vanilloid receptor 1 (TRPV1) dependent mechanism
S. Harrison, M. Trevisani, F. Benvenuti, M. Rigoni, B. Campi, P. Geppetti (Ferrara, Florence, Italy)
| |
Influence of sympatho-vagal modulation on airway hyperresponsivness
A. P. Pichon, C. de Bisschop, A. Denjean (Poitiers, France)
| |
The triple neurokinin receptor antagonist CS-003 inhibits neurokinin A (NKA)-induced bronchoconstriction in patients with asthma
V. Schelfhout, R. Louis, W. Lenz, R. Pauwels, G. Joos (Ghent, Liege, Belgium)
| |